Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Moore

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
Progress in Clinical and Biological Research|January 1, 1987
Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC)P M Sondel, J A Hank, N Rosenthal, et al.
Analytical Biochemistry|May 1, 1993
Lactate oxidation for the detection of mitochondrial dysfunction in human skin fibroblastsJ P Ofenstein, F L Kiechle, D M Dandurand, et al.
European Journal of Clinical Pharmacology|April 11, 2001
Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitorK H Moore, L M Cass, N Dallow, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 24, 2021
The association between nocturia, hormonal symptoms and bladder parameters in women: an observational studyW F Bower, G E Rose, D M Whishaw, et al.
Journal of the National Cancer Institute|March 2, 1988
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicityJ A Sosman, P C Kohler, J Hank, et al.
Journal of Clinical Pharmacology|October 5, 2001
Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteersK H Moore, L M Cass, N Dallow, et al.
Journal of the National Cancer Institute|November 16, 1988
Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacinJ A Sosman, P C Kohler, J A Hank, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazoleK H Moore, G J Yuen, R H Raasch, et al.
Journal of Clinical Pharmacology|July 17, 2001
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hoursD Moodley, K Pillay, K Naidoo, et al.
American Journal of Obstetrics and Gynecology|November 21, 2000
Localization of messenger ribonucleic acid for adrenomedullin and adrenomedullin receptor in the human placenta in normal pregnancies and pregnancies complicated by oligohydramniosC C Apodaca, K H Moore, T M Rossignol, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Progress in Clinical and Biological Research|January 1, 1987
Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC)P M Sondel, J A Hank, N Rosenthal, et al.
Analytical Biochemistry|May 1, 1993
Lactate oxidation for the detection of mitochondrial dysfunction in human skin fibroblastsJ P Ofenstein, F L Kiechle, D M Dandurand, et al.
European Journal of Clinical Pharmacology|April 11, 2001
Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitorK H Moore, L M Cass, N Dallow, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|May 24, 2021
The association between nocturia, hormonal symptoms and bladder parameters in women: an observational studyW F Bower, G E Rose, D M Whishaw, et al.
Journal of the National Cancer Institute|March 2, 1988
Repetitive weekly cycles of recombinant human interleukin-2: responses of renal carcinoma with acceptable toxicityJ A Sosman, P C Kohler, J Hank, et al.
Journal of Clinical Pharmacology|October 5, 2001
Pharmacokinetics and tolerability of GW420867X, a nonnucleoside reverse transcriptase inhibitor, following single escalating doses in healthy male volunteersK H Moore, L M Cass, N Dallow, et al.
Journal of the National Cancer Institute|November 16, 1988
Repetitive weekly cycles of interleukin-2. II. Clinical and immunologic effects of dose, schedule, and addition of indomethacinJ A Sosman, P C Kohler, J A Hank, et al.
Clinical Pharmacology and Therapeutics|May 1, 1996
Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazoleK H Moore, G J Yuen, R H Raasch, et al.
Journal of Clinical Pharmacology|July 17, 2001
Pharmacokinetics of zidovudine and lamivudine in neonates following coadministration of oral doses every 12 hoursD Moodley, K Pillay, K Naidoo, et al.
American Journal of Obstetrics and Gynecology|November 21, 2000
Localization of messenger ribonucleic acid for adrenomedullin and adrenomedullin receptor in the human placenta in normal pregnancies and pregnancies complicated by oligohydramniosC C Apodaca, K H Moore, T M Rossignol, et al.
Pageof 11